The A-share biopharmaceutical sector continues to strengthen, with Maccura, Hybribio Biotech, and KHB hitting the daily limit up in the afternoon. LIFERIVER and DAJY had previously reached their limit up, while WONDFO BIOTECH, ACROBIOSYSTEMS, Orient Biotech, and SSSW rose over 10%Wallstreetcn·Jan 25 at 11:15 PM688317+0.63%0020220.00%
LIFERIVER released its performance for the first three quarters, with a net loss attributable to the parent company of 29.38 million yuanZhitong·Oct 29, 2025 at 05:21 AM688317+0.63%
LIFERIVER: Plans to repurchase shares for 60 million to 120 million yuanZhitong·Oct 16, 2025 at 05:11 AM688317+0.63%
LIFERIVER: Monkeypox virus nucleic acid testing kit (fluorescent PCR method) included in WHO emergency use listZhitong·Sep 18, 2025 at 04:13 AM688317+0.63%
LIFERIVER: Has established a product line for the detection of mosquito-borne infectious diseases, including the Chikungunya virusZhitong·Aug 1, 2025 at 02:46 AM688317+0.63%
Monkeypox concept stocks surged, KHB hit the limit upZhitong·Jul 27, 2025 at 08:33 PM0023700.00%0020220.00%
LIFERIVER has obtained relevant certifications for multiple productsZhitong·Jul 16, 2025 at 02:42 AM688317+0.63%
LIFERIVER has repurchased 3.12% of its shares at a cost of 102 million yuanZhitong·Apr 8, 2025 at 03:09 AM688317+0.63%
LIFERIVER obtained a medical device registration certificateZhitong·Mar 26, 2025 at 04:47 AM688317+0.63%
LIFERIVER has repurchased 2.08% of its shares, costing 68.7089 million yuanZhitong·Mar 11, 2025 at 05:10 AM688317+0.63%
LIFERIVER reported a net loss of 128 million yuan for the fiscal year 2024Zhitong·Feb 27, 2025 at 01:56 AM688317+0.63%
Overview of A-share Stock Buybacks: 15 Companies Disclose Buyback ProgressZhitong·Feb 25, 2025 at 05:36 PM300712-2.36%3006850.00%
LIFERIVER: Plans to implement the 2025 valuation enhancement planZhitong·Feb 25, 2025 at 05:32 AM688317+0.63%
